Related Experiment Video
Updated: Jun 3, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Cortical pathology and cognitive impairment in multiple sclerosis
Massimiliano Calabrese1, Francesca Rinaldi, Paola Grossi
1Multiple Sclerosis Centre of Veneto Region, First Neurology Clinic, Department of Neurosciences, University Hospital of Padova, Padova, 35128, Italy.
Expert Review of Neurotherapeutics
|March 8, 2011
Summary
Cognitive impairment in multiple sclerosis (MS) is linked to cortical abnormalities, not just white matter lesions. MRI evaluation of cortical pathology is crucial for MS patients with cognitive issues.
Area of Science:
- Neuroscience
- Radiology
- Immunology
Background:
- Cognitive impairment affects 40-65% of multiple sclerosis (MS) patients.
- Traditional MRI and pathology studies show weak correlations between cognitive deficits and subcortical white matter lesions or whole-brain atrophy.
- Emerging evidence suggests cortical pathology plays a primary role in MS-related cognitive dysfunction.
Purpose of the Study:
- To investigate the relationship between cortical structural abnormalities and cognitive impairment in multiple sclerosis.
- To determine if cortical pathology better explains cognitive deficits than subcortical white matter lesions.
- To evaluate the utility of advanced MRI techniques for assessing cortical pathology in MS.
Main Methods:
- Utilized semi-automated software (Freesurfer) to analyze global and regional cortical thickness.
- Employed double inversion recovery (DIR) MRI sequences to identify cortical lesions.
- Correlated MRI findings of cortical pathology with specific cognitive deficits.
Main Results:
- Cortical structural abnormalities, including focal lesions and reduced cortical thickness, are strongly associated with cognitive impairment in MS.
- Specific deficits like memory impairment, attention deficits, and reduced processing speed are better explained by cortical pathology.
- Subcortical white matter lesions and overall brain atrophy showed a weaker correlation with cognitive dysfunction.
Conclusions:
- Cortical pathology, rather than subcortical white matter lesions, is a key driver of cognitive impairment in multiple sclerosis.
- Advanced MRI assessment of cortical thickness and lesions should be integrated into routine MS patient evaluation.
- Early identification of cortical abnormalities may aid in managing cognitive dysfunction in MS.
More Related Videos
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...